Top Story
Attack Mounts on Extended Drug Exclusivity
Public outrage over more high-priced drugs is undermining support for provisions in the House-passed 21st Century Cures legislation that provide additional exclusivities for developing certain new therapies, writes Jill Wechsler
...Read more |
 |
Biosimilars
Does Interchangeability Really Matter for Biosimilars?
While waiting for FDA issue much-anticipated guidance on how to test and gain approval of interchangeable therapies, biosimilar makers acknowledge the need to educate doctors and pharmacy benefit managers (PBMs) on how biosimilars are equally safe and effective as their reference products, and offer better value
...Read more |
 |
Europe
Breaking Out of the Best-Practice Cycle
The European Commission’s 'Expert panel on effective ways of investing in health' is urging more radical solutions based on theories of disruptive innovation. The approach could, if adopted in policy, lead to a more conducive environment for bringing useful new products to the market in Europe, writes Reflector
...Read more |
 |
Marketing
Think Globally, Act Locally
We now have the capacity with the click of a button to disseminate our message all over the world, instantaneously. But marketers know the path from globalization to localization is an important one, in which steps can't be skipped. So what are the keys to getting a global message to become a local message in today's digital world?
...Read more |
 |
Event
Prix Galien Panel Stirs on Pricing
Prix Galien USA’s Forum took on the big questions confronting the industry last week, namely drug pricing. US Health Reform: Partnering, Pricing and Politics, was clearly the most anticipated session of the event, judging by the standing room only crowd. Casey McDonald reports
...Read more |
Pharmaceutical Executive E-Book – Coming November 2015: Securing the Global Supply Chain: Strategies for Operational Excellence
Key Topics include:
- Compliance Groundswell: What are the New Rules and Regulator Expectations?
- Global Dynamics of Risk: Can Technology Keep Pace?
- Benchmarking Best Practices: Upgrading Company Performance Culture
- What's Ahead: How Logistics and Distribution Science will Shape Tomorrow's Supply Chain
 Contact your sales rep for more information and to secure your sponsorship. |
 |
 //Lion Biotechnologies (New York, NY) announced that Dr. Laszlo Radvanyi is leaving his position as Chief Scientific Officer of the company.//Arog Pharmaceuticals (Dallas, TX) announced the appointment of Ada Braun, M.D., Ph.D., as Senior Vice President of Clinical Development.//Biota Pharmaceuticals (Atlanta, GA) announced today the appointment of Mark P. Colonnese as Executive Vice President and Chief Financial Officer.//Galena Biopharma (San Ramon, CA) hired Bijan Nejadnik, M.D., as its Executive Vice President and Chief Medical Officer.// |
|
U.S. Market Access
Key Learnings from a recent success story
Live Webinar: Thursday, November 19th, 2015 at 11 AM EST
Join Randolph Carpio from Quintiles, and Joe Bonaccorso from Pierre Fabre as they discuss the importance of getting the reimbursement, access and distribution strategy correct to make the most of the opportunities in the U.S.
 Register for free Webinar
|
|
|
|
